FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995909802> ?p ?o ?g. }

• W1995909802 endingPage "334" @default.
• W1995909802 startingPage "326" @default.
• W1995909802 abstract "Heat-labile opsonic activity was measured simultaneously in serum and pleural fluid of patients with transudates, infectious exudates (with positive or negative bacterial culture) and neoplastic exudates, using two different complement-dependent phagocytic tests: the killing of Staphylococcus aureus Wood 46 variant strain (K50 opsonic titers) and the assessment of ingestion rate of endotoxin-coated paraffin particles (Oil Red 0 uptake test). K50 opsonic titers were lower in culture-positive pleural effusions as compared to culture-negative (P < 0.002) or neoplastic effusions (P < 0.002). These results were corroborated by the Oil Red 0 uptake test. The data obtained with the two assays showed a significant correlation (P < 0.001). The hemolytic activity of complement (CH50) as well as the levels of C3 breakdown product, C3d, were measured in the same sera and pleural fluid samples and in an additional group of patients with pleural effusions of the same etiology. Effusions with positive cultures showed lower CH50 values (P < 0.01) and higher C3d values (P < 0.05) when compared to culture-negative pleural fluids. Finally, evidence for immune complexes in pleural effusions and sera was looked for by determination of Clq binding activity. Levels were higher in culture-positive effusions when compared to culture-negative fluids (P = 0.005).K50 opsonic titers showed a positive correlation with CH50 values (P < 0.001) for all fluids tested. Similarly Clq binding activity correlated with C3d levels in effusions of infectious origin (P = 0.05). Recovery experiments using the various bacterial species isolated from culture-positive pleural effusions showed evidence of complement inactivation upon incubation with pooled sera at concentrations of 10(7)-10(8) microorganisms/ml. These results indicate that one important reason for bacterial persistence in empyema may be decreased opsonization secondary to local consumption of complement." @default.
• W1995909802 created "2016-06-24" @default.
• W1995909802 creator A5001893799 @default.
• W1995909802 creator A5029264019 @default.
• W1995909802 creator A5031931128 @default.
• W1995909802 creator A5069420480 @default.
• W1995909802 creator A5074268731 @default.
• W1995909802 creator A5088674368 @default.
• W1995909802 date "1979-02-01" @default.
• W1995909802 modified "2023-10-12" @default.
• W1995909802 title "Decreased Heat-Labile Opsonic Activity and Complement Levels Associated with Evidence of C3 Breakdown Products in Infected Pleural Effusions" @default.
• W1995909802 cites W1496693115 @default.
• W1995909802 cites W1520385356 @default.
• W1995909802 cites W1548060716 @default.
• W1995909802 cites W1554350352 @default.
• W1995909802 cites W1590052573 @default.
• W1995909802 cites W173509265 @default.
• W1995909802 cites W1761110280 @default.
• W1995909802 cites W1965613740 @default.
• W1995909802 cites W1995439274 @default.
• W1995909802 cites W2015556298 @default.
• W1995909802 cites W2023863882 @default.
• W1995909802 cites W2039939672 @default.
• W1995909802 cites W2053863419 @default.
• W1995909802 cites W2063989378 @default.
• W1995909802 cites W2064814300 @default.
• W1995909802 cites W2079769743 @default.
• W1995909802 cites W2082563075 @default.
• W1995909802 cites W2098634494 @default.
• W1995909802 cites W2122313055 @default.
• W1995909802 cites W2141137504 @default.
• W1995909802 cites W2155897042 @default.
• W1995909802 cites W2158300157 @default.
• W1995909802 cites W2227120101 @default.
• W1995909802 cites W2316219066 @default.
• W1995909802 cites W2331513080 @default.
• W1995909802 cites W2402872445 @default.
• W1995909802 cites W1891397857 @default.
• W1995909802 cites W2137913192 @default.
• W1995909802 doi "https://doi.org/10.1172/jci109306" @default.
• W1995909802 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/371956" @default.
• W1995909802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/429556" @default.
• W1995909802 hasPublicationYear "1979" @default.
• W1995909802 type Work @default.
• W1995909802 sameAs 1995909802 @default.
• W1995909802 citedByCount "58" @default.
• W1995909802 countsByYear W19959098022012 @default.
• W1995909802 countsByYear W19959098022014 @default.
• W1995909802 countsByYear W19959098022022 @default.
• W1995909802 crossrefType "journal-article" @default.
• W1995909802 hasAuthorship W1995909802A5001893799 @default.
• W1995909802 hasAuthorship W1995909802A5029264019 @default.
• W1995909802 hasAuthorship W1995909802A5031931128 @default.
• W1995909802 hasAuthorship W1995909802A5069420480 @default.
• W1995909802 hasAuthorship W1995909802A5074268731 @default.
• W1995909802 hasAuthorship W1995909802A5088674368 @default.
• W1995909802 hasBestOaLocation W19959098021 @default.
• W1995909802 hasConcept C126322002 @default.
• W1995909802 hasConcept C159654299 @default.
• W1995909802 hasConcept C185592680 @default.
• W1995909802 hasConcept C203014093 @default.
• W1995909802 hasConcept C2778978224 @default.
• W1995909802 hasConcept C2779634585 @default.
• W1995909802 hasConcept C2993292583 @default.
• W1995909802 hasConcept C32611913 @default.
• W1995909802 hasConcept C71924100 @default.
• W1995909802 hasConcept C86803240 @default.
• W1995909802 hasConcept C89372155 @default.
• W1995909802 hasConcept C89423630 @default.
• W1995909802 hasConceptScore W1995909802C126322002 @default.
• W1995909802 hasConceptScore W1995909802C159654299 @default.
• W1995909802 hasConceptScore W1995909802C185592680 @default.
• W1995909802 hasConceptScore W1995909802C203014093 @default.
• W1995909802 hasConceptScore W1995909802C2778978224 @default.
• W1995909802 hasConceptScore W1995909802C2779634585 @default.
• W1995909802 hasConceptScore W1995909802C2993292583 @default.
• W1995909802 hasConceptScore W1995909802C32611913 @default.
• W1995909802 hasConceptScore W1995909802C71924100 @default.
• W1995909802 hasConceptScore W1995909802C86803240 @default.
• W1995909802 hasConceptScore W1995909802C89372155 @default.
• W1995909802 hasConceptScore W1995909802C89423630 @default.
• W1995909802 hasIssue "2" @default.
• W1995909802 hasLocation W19959098021 @default.
• W1995909802 hasLocation W19959098022 @default.
• W1995909802 hasLocation W19959098023 @default.
• W1995909802 hasLocation W19959098024 @default.
• W1995909802 hasLocation W19959098025 @default.
• W1995909802 hasLocation W19959098026 @default.
• W1995909802 hasOpenAccess W1995909802 @default.
• W1995909802 hasPrimaryLocation W19959098021 @default.
• W1995909802 hasRelatedWork W109198006 @default.
• W1995909802 hasRelatedWork W1812950566 @default.
• W1995909802 hasRelatedWork W1921744819 @default.
• W1995909802 hasRelatedWork W1954611278 @default.
• W1995909802 hasRelatedWork W1995909802 @default.
• W1995909802 hasRelatedWork W2052276121 @default.
• W1995909802 hasRelatedWork W2237794707 @default.
• W1995909802 hasRelatedWork W2393024304 @default.

• next